HELICOBACTER PYLORI INFECTION: A BIOINFORMATIC APPROACH

被引:12
|
作者
Prasad, Ashwini [1 ]
Shruthi, Govindaraju [1 ]
Sushma, P. [1 ]
Jain, Anisha S. [1 ]
Chandan, D. [1 ]
Prasad, M. N. Nagendra [2 ]
Kollur, Shiva Prasad
Srinivasa, Chandrashekar [3 ]
Shivamallu, Chandan [1 ]
机构
[1] JSS Acad Higher Educ & Res, Fac Life Sci, Dept Water & Hlth, Mysore 570015, Karnataka, India
[2] JSS Sci & Technol Univ, Sri Jayachamarajendra Coll Engn, Dept Biotechnol, Mysore 570015, Karnataka, India
[3] Davangere Univ, Dept Biotechnol, Davanagere 577007, Karnataka, India
关键词
In-silico Analysis; Molecular Docking; Molecular Interaction; Helicobacter pylori;
D O I
10.13040/IJPSR.0975-8232.11(11).5469-83
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Helicobacter pylori causative agent of acid peptic disease is a microaerophilic, spiral-shaped, gram-negative bacteria found in the gastric epithelium that may also lead to complications such as chronic gastritis, mucosa-associated lymphoid tissue (MALT) lymphoma, gastroduodenal ulcer and adenocarcinoma in stomach. Plantbioactives have always been potential therapeutics. Usage of modern bioinformatic tools plays a vital role in exploiting the potentials of alternative therapeutic molecules in managing diseases like peptic ulcers and their complications. The in-silico evaluation was carried out using molecular docking of the quorum sensing proteins of H. pylori with the ligand beta-sitosterol obtained from the silver nanoparticles of Acorus calamus L. Among several given quorum sensing proteins the molecular interaction with the ligand beta-sitosterol showed a high binding affinity with DnaA, PhnB, ToxB and Sip proteins. The results obtained from molecular interaction study revealed that the ligand beta-sitosterol will be readily taken up by the organism, thereby facilitating easy inhibition or inactivation of quorum sensing molecules ToxB, DnaA, PhnB, and Sip, making it a novel therapeutic alternative to treat H. pylori infections.
引用
收藏
页码:5469 / 5483
页数:15
相关论文
共 50 条
  • [1] Approach to Helicobacter pylori infection in children
    Hassall, E
    HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 575 - 585
  • [2] Personalized Approach in Eradication of Helicobacter pylori Infection
    Mestrovic, Antonio
    Perkovic, Nikola
    Tonkic, Ante
    Sundov, Zeljko
    Kumric, Marko
    Bozic, Josko
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [3] Approach to Helicobacter pylori infection in geriatric population
    Sevdenur Cizginer
    Zehra Ordulu
    Abdurrahman Kadayifci
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2014, (03) : 139 - 147
  • [4] Modern approach to the diagnosis of Helicobacter pylori infection
    Dore, Maria Pina
    Graham, David Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 : S14 - S21
  • [5] APPROACH TO HELICOBACTER PYLORI INFECTION IN SPECIFIC AGE GROUPS
    Stefanescu, Gabriela
    Balan, Gheorghe G.
    Gilca-Blanariu, Georgiana Emmanuela
    Olaru, Claudia
    Timofte, Oana
    Gimiga, Nicoleta
    Rosu, Oana-Maria
    Anton, Emil
    Ion, Laura Mihaela
    Diaconescu, Smaranda
    INTERNATIONAL JOURNAL OF MEDICAL DENTISTRY, 2018, 22 (02) : 113 - 121
  • [6] Review article:: an approach to Helicobacter pylori infection in the elderly
    Pilotto, A
    Malfertheiner, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) : 683 - 691
  • [7] An Updated Approach to Evaluation and Treatment of Helicobacter pylori Infection
    Lloyd, Benjamin R.
    Leiman, David A.
    SOUTHERN MEDICAL JOURNAL, 2019, 112 (07) : 392 - 398
  • [8] Helicobacter pylori infection
    Vandenplas, Y
    WORLD JOURNAL OF GASTROENTEROLOGY, 2000, 6 (01) : 20 - 31
  • [9] Helicobacter pylori infection
    Delaney, BC
    Moayyedi, P
    Forman, D
    AMERICAN FAMILY PHYSICIAN, 2003, 67 (11) : 2359 - 2360
  • [10] Helicobacter pylori Infection
    Graham, David Y.
    Dang, Bich N.
    El-Serag, Hashem B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (06): : 587 - 588